Our history
the power of
disruptive
collaboration
Building momentum
for good
2025
CivicaScript launches dalfampridine extended-release tablets in August.
CivicaScript launches capecitabine tablets in July.
CivicaScript launches dimethyl fumarate delayed-release capsules in June.
CivicaScript launches droxidopa capsules in April.
2024
New president hired
Brent Eberle, RPh, MBA, joins CivicaScript as president.
2023
Two new partnering members join
- Boilermakers National Health and Welfare Fund
- Nonprofit PBM Scripius (formerly SelectHealth)
2022
First product launched
CivicaScript launches abiraterone 250 mg tablets.
First pharmacy benefit manager (PBM) joins
Affirmed Rx joins as a partnering member.
Two more founding members join
- PBM Navitus Health Solutions
- Health Care Service Corporation
2021
New founding member joins
Elevance Health (formerly Anthem, Inc.), which operates affiliated health plans that cover more than 47 million people in the U.S.
2020
CivicaScript is created
CivicaScript is co-founded by Civica, the Blue Cross Blue Shield Association, and 18 independent and locally operated Blue Cross and Blue Shield companies.
CivicaScript model delivers significant patient and payer savings. Learn more >
